Sugi Predict

Sugi Predict / Compounds / SCHEMBL12427256

SCHEMBL12427256

SCHEMBL12427256

CCOC(=O)C(=CNC(C)CF)C(=O)c1cc(F)c(F)c(OC)c1F

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.33
▸ MEN1 O00255 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ NPSR1 Q6W5P4 4/20 0.33
▸ LMNA P02545 4/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ DHODH Q02127 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ GAA P10253 6/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ PLIN1 O60240 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ PLIN5 Q00G26 1/20 0.32
▸ ABHD5 Q8WTS1 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.31
▸ HPGD P15428 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12916941 0.90 MAPT (0.35) MAPTMEN1KMT2ANPSR1LMNA
SCHEMBL14435373 0.89 — —
SCHEMBL12427255 0.86 NPSR1 (0.36) MAPTMEN1KMT2ANPSR1LMNA
SCHEMBL12916928 0.86 NPSR1 (0.36) MAPTMEN1KMT2ANPSR1LMNA
SCHEMBL12427259 0.85 SMN1; SMN2 (0.37) MAPTMEN1KMT2ANPSR1LMNA
SCHEMBL1345256 0.81 GAA (0.37) MAPTMEN1KMT2ANPSR1LMNA
SCHEMBL12130969 0.81 GAA (0.37) MAPTMEN1KMT2ANPSR1LMNA
SCHEMBL1345257 0.81 GAA (0.37) MAPTMEN1KMT2ANPSR1LMNA
SCHEMBL6511932 0.80 MEN1 (0.36) MAPTMEN1KMT2ANPSR1LMNA
SCHEMBL5534138 0.80 MEN1 (0.36) MAPTMEN1KMT2ANPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977349-B2 Substituted quinolones III AICURIS GMBH & CO. KG (DE) 2011-07-12 — — US disclosed
US-7977349-B2 Substituted quinolones III AICURIS GMBH & CO. KG (DE) 2011-07-12 — — US disclosed
EP-1994020-B1 Substituted quinolones III AICURIS GMBH & CO KG (DE) 2011-06-22 — — EP disclosed
US-7867992-B2 such as 1-Cyclopropyl-N-(2,4-dichlorobenzyl)-6-fluoro-8-methoxy-7-[3-methyl-4-(2-{[(methylamino)carbonyl]amino}-2-oxoethyl)piperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxamide, used for the treatment and/or prophylaxis of viral diseases or infections, particularly against cytomegaloviruses AICURIS GMBH & CO. KG (DE) 2011-01-11 — — US disclosed
US-20090181996-A1 SUBSTITUTED QUINOLONES III BAYER HEALTHCARE AG (DE) 2009-07-16 — — US disclosed
US-20090181996-A1 SUBSTITUTED QUINOLONES III BAYER HEALTHCARE AG (DE) 2009-07-16 — — US disclosed
US-20070293478-A1 Substituted quinolones BAYER HEALTHCARE AG (DE) 2007-12-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181996-A1 SUBSTITUTED QUINOLONES III IRF3, TPMT, TOP2A MAPT 3333/4885MEN1 2183/4885KMT2A 2178/4885
US-20070293478-A1 Substituted quinolones IRF3, TPMT, NQO2 MAPT 2548/4885MEN1 1851/4885KMT2A 2156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.